@windhamvp

CVRx® Announces Publication of BeAT-HF Clinical Study Results in the Journal of The American College of Cardiology

BAROSTIM NEO™ is the World’s First Heart Failure Neuromodulation Device MINNEAPOLIS, June 30, 2020 /PRNewswire/ — CVRx, Inc., a private medical device company, announced today that its BeAT-HF phase III randomized clinical … Continued

Laura Chambers, Former AirBnB, eBay Exec & Mom of 3, Takes the Helm of Femtech Leader Willow® as CEO

Chambers joins as CEO as Willow reports record-breaking growth:– 120% growth in its mom user base year-over-year– 140% increase in revenue year-over-year– Expects to grow 2019 revenue by nearly 50%– … Continued

FDA Issues Emergency Use Authorization for ChromaCode’s High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

High-Definition PCR SARS-CoV-2 assay increases test throughput and reduces complexity of interpretation; ChromaCode customers enjoy inventory guarantee CARLSBAD, Calif., June 10, 2020 /PRNewswire/ — ChromaCode, Inc., a company redefining molecular testing through … Continued

Neuspera Medical Completes First Implants of its Neuromodulation Device in its two-stage Pivotal Clinical Trial to treat Urinary Urgency Incontinence

Ultra-Miniaturized Device is Smallest-Known Sacral Nerve Implant SAN JOSE, Calif., June 10, 2020 /PRNewswire/ — Neuspera Medical Inc., a privately held, clinical stage medical device company, today announced the completion of the … Continued

Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device

Inspire Medical Systems CEO Tim Herbert has joined Nuvaira Board of Directors MINNEAPOLIS, June 8, 2020 /PRNewswire/ — Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that … Continued